Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Bristol-Myers Squibb Co    BMY

Delayed Quote. Delayed  - 07/22 10:02:36 pm
75.68 USD   +0.24%
07/20 BRISTOL MYERS S : Announces Availability of FDA-Approved ORENCIA® (a..
07/18 BRISTOL MYERS S : Announces Regulatory Updates for Opdivo (nivolumab..
07/14 BRISTOL MYERS S : Young scientists participate in Bristol-Myers Squi..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/18/2016 07/19/2016 07/20/2016 07/21/2016 07/22/2016 Date
75.96(c) 75.47(c) 75.72(c) 75.5(c) 75.68(c) Last
3 794 127 3 693 247 3 949 784 3 420 459 5 266 828 Volume
-0.05% -0.65% +0.33% -0.29% +0.24% Change
More quotes
Financials ($)
Sales 2016 18 581 M
EBIT 2016 4 900 M
Net income 2016 4 106 M
Debt 2016 814 M
Yield 2016 2,05%
Sales 2017 20 836 M
EBIT 2017 6 329 M
Net income 2017 5 279 M
Finance 2017 1 211 M
Yield 2017 2,18%
P/E ratio 2016 30,48
P/E ratio 2017 24,30
EV / Sales2016 6,84x
EV / Sales2017 6,01x
Capitalization 126 333 M
More Financials
Company
Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
07/28 | 12:59pmEarnings Release
More about the company
Surperformance© ratings of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More Ratings
Latest news on BRISTOL-MYERS SQUIBB CO
07/21 REPORTS SUMMARIZE PHARMACOKINETICS F : The Segregated Flow Model for Intestinal ..
07/21 BRISTOL MYERS SQUIBB : Reports Outline Hepatitis C Virus Study Results from Bris..
07/20 BRISTOL MYERS SQUIBB : Announces Availability of FDA-Approved ORENCIA® (abatacep..
07/18 BRISTOL MYERS SQUIBB : Announces Regulatory Updates for Opdivo (nivolumab) in Pr..
07/14 BRISTOL MYERS SQUIBB : Acquires Cormorant Pharmaceuticals
07/14 BRISTOL MYERS SQUIBB : New Apoptosis Regulatory Proteins Findings from Bristol-M..
07/14 BRISTOL MYERS SQUIBB : Findings from Bristol-Myers Squibb Broaden Understanding ..
07/14 BRISTOL MYERS SQUIBB : Researchers from Bristol-Myers Squibb Report Findings in ..
07/14 BRISTOL MYERS SQUIBB : Young scientists participate in Bristol-Myers Squibb's Sc..
07/13 ADVAXIS : Appoints Ranya Dajani as Vice President, Corporate Development
More news
Sector news : Pharmaceuticals - NEC
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJBAYER : 2Q 2016 -- Forecast
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
07/21DJBIOGEN : Announces CEO Search, Lifts Guidance--2nd Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/21 The Perfect Dividend Portfolio
07/20 New Approvals Provide Reason For Optimism In 2016
07/20 ELI LILLY : Executive Compensation And Other Metrics
07/20 Tips To Play The Earnings Season - Cramer's Mad Money (7/19/16)
07/20 Abiomed Is Expensive - Cramer's Lightning Round (7/19/16)
Advertisement
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Technical analysis trends BRISTOL-MYERS SQU...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 77,0 $
Spread / Average Target 1,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Giovanni Caforio Chief Executive Officer & Director
Lamberto Andreotti Chairman
Charles A. Bancroft Chief Financial Officer & Executive Vice President
Francis M. Cuss Chief Scientific Officer & Executive VP
Paul von Autenried Chief Information Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BRISTOL-MYERS SQUIBB C..10.02%126 333
JOHNSON & JOHNSON21.72%343 913
PFIZER INC.13.82%222 823
NOVARTIS AG-5.53%219 526
ROCHE HOLDING LTD.-9.55%218 832
MERCK & CO., INC.11.36%162 815
More Results